Adebrelimab trials for Breast cancer

All Adebrelimab trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Adebrelimab for Breast cancer

• Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer
  NCT06149130 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis
  NCT06418594 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer
  NCT06433609 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Adebrelimab for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.